Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tracy E. Campbell"'
Autor:
Christian S. Hinrichs, William C. Faquin, Stacey L. Doran, Sanja Stevanović, Sarah R. Helman, Tracy E. Campbell, Mei Li M. Kwong
Publikováno v:
JAMA Network Open
Key Points Question Does the cross-reactivity of T cells against the human papillomavirus (HPV) oncoproteins in HPV-positive cancers support current immunotherapeutic vaccine clinical trial designs in which the HPV type of the tumor is not matched wi
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model
Autor:
Sanja Stevanović, Christian S. Hinrichs, Lindsey Draper, Steven A. Rosenberg, Cornelia L. Trimble, Tracy E. Campbell, Benjamin Y. Jin, Bianca Weissbrich, Zhiya Yu, Nicholas P. Restifo
Publikováno v:
JCI Insight. 3
T cell receptor (TCR) T cell therapy is a promising cancer treatment modality. However, its successful development for epithelial cancers may depend on the identification of high-avidity TCRs directed against tumor-restricted target antigens. The hum
Use of Nucleic Acid Amplification Testing for Diagnosis of Anorectal Sexually Transmitted Infections
Autor:
Tracy Zamborsky, Abi Jett, Tracy E. Campbell, Sharon L. Hillier, Ingrid Macio, Ross D. Cranston, Lisa A. Cosentino
Publikováno v:
Journal of Clinical Microbiology. 50:2005-2008
Nucleic acid amplification testing (NAAT) has become the preferred method to detect Chlamydia trachomatis and Neisseria gonorrhoeae , but no commercial tests are cleared by the U.S. Food and Drug Administration for use with rectal swab samples. This
Autor:
John R. Wunderlich, Nicholas P. Restifo, Steven A. Rosenberg, Udai S. Kammula, Sanja Stevanović, Mei Li Kwong, Tracy E. Campbell, Mark E. Dudley, Michelle M. Langhan, Lindsey Draper, James Chih-Hsin Yang, Richard M. Sherry, Christian S. Hinrichs
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(14)
Purpose Metastatic cervical cancer is a prototypical chemotherapy-refractory epithelial malignancy for which better treatments are needed. Adoptive T-cell therapy (ACT) is emerging as a promising cancer treatment, but its study in epithelial malignan
Autor:
Robert D. Kirkcaldy, Shacondra M. Johnson, Alesia Harvey, Jonathan M. Zenilman, Connie Lenderman, Abi Jett, Kevin Pettus, Carol L. Priest, Jeannette Y. Lee, Shannon Fuller, Amelia Herrera, Samera Sharpe, Jennifer Vonghack, Harold C. Wiesenfeld, Susan S. Philip, Linda McNeil, Carolyn D. Deal, Nikole Trainor, Ingrid Macio, Jonathan Glock, Shelly Lensing, Deborah Dowell, Lalitha Venkatasubramanian, Khalil G. Ghanem, Jonathan S. Carlson, Marisol Mejia, Jill Long, Peter R. Kerndt, Tracy E. Campbell, Allison Whittington, Hillard Weinstock, Edward W. Hook, Lori M. Newman, LaShawnda Royal, Apurva Uniyal, Page C. Moore, Susan Tobias, Paula Dixon, John R. Papp, Hanne S. Harbison, Charlotte Perlowski
Background. Ceftriaxone is the foundation of currently recommended gonorrhea treatment. There is an urgent need for backup treatment options for patients with cephalosporin allergy or infections due to suspected cephalosporin-resistant Neisseria gono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c67e30837b3e7059c539015c1c6d2cb
https://europepmc.org/articles/PMC4271098/
https://europepmc.org/articles/PMC4271098/